The ASXL1 gene alterations in patients with 20q deletion

被引：0
|
作者：
Brezinova, Jana [1 ]
Sarova, Iveta [1 ]
Lhotska, Halka [2 ,3 ]
Ransdorfova, Sarka [1 ]
Izakova, Silvia [2 ,3 ]
Svobodova, Karla [2 ,3 ]
Markova, Jana [4 ]
Zemanova, Zuzana [2 ,3 ]
Cermak, Jaroslav [5 ]
Jonasova, Anna [6 ,7 ]
Michalova, Kyra [2 ,3 ]
机构：
[1] Inst Hematol & Blood Transfus, Dept Cytogenet, Prague, Czech Republic
[2] ULBLD, Gen Univ Hosp, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Ctr Oncocytogenet, Prague, Czech Republic
[4] Inst Hematol & Blood Transfus, Dept Mol Genet, Prague, Czech Republic
[5] Inst Hematol & Blood Transfus, Clin Dept, Prague, Czech Republic
[6] Gen Univ Hosp, Prague, Czech Republic
[7] Charles Univ Prague, Fac Med 1, Dept Med 1, Prague, Czech Republic
来源：
CHROMOSOME RESEARCH | 2015年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2.P12
引用
收藏
页码：S80 / S81
页数：2
相关论文
共 50 条
  • [31] A 20Q DELETION ORIGINATING IN A PLURIPOTENT STEM-CELL
    HOLLINGS, PE
    ROSMAN, I
    BEARD, MEJ
    BLOOD, 1994, 83 (01) : 305 - 306
  • [32] Spectrum of Gene Mutations and Clinical Significance in Myeloid Malignancies Patients with ASXL1 Mutations
    Bai, Jie
    Teng, Guangshuai
    Wang, Yingshao
    Xu, Jing
    Du, Chenxiao
    Wang, Yan
    Chen, Yafang
    Sheng, Mengyao
    Bai, Jiaojiao
    Zhang, Lei
    Zhou, Yuan
    Yang, Feng-Chun
    BLOOD, 2018, 132
  • [33] GENE EXPRESSION PROFILE IN PRIMARY MYELOFIBROSIS: ROLE OF ASXL1
    Sanchez Sosa, S.
    Bilbao Sieyro, C.
    Florido Ortega, Y.
    Gonzalez Perez, E.
    Saez Perdomo, M. N.
    Stuckey, R.
    Santana Santana, G.
    Molero Labarta, M. T.
    Loro Ferrer, J. F.
    Gomez Casares, M. T.
    HAEMATOLOGICA, 2019, 104 : 248 - 248
  • [34] MUTATIONS OF ASXL1 GENE IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETIC PROFILE
    Markova, J.
    Michkova, P.
    Maaloufova, J. Soukupova
    Soukup, P.
    Salek, C.
    Brezinova, J.
    Michalova, K.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA, 2014, 99 : 558 - 559
  • [35] Dominant genetic alterations in immortalization: Role for 20q gain
    Cuthill, S
    Agarwal, P
    Sarkar, S
    Savelieva, E
    Reznikoff, CA
    GENES CHROMOSOMES & CANCER, 1999, 26 (04): : 304 - 311
  • [36] Clinical and Bone Marrow Features of Patients With Isolated 20q Deletion: A Developing World Perspective
    Bhat, Rekha
    Pai, Swati
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A143 - A143
  • [37] Acquired elliptocytosis in a patient with a myelodysplastic syndrome associated with 20q deletion
    Quiroz-Cervantes, Keina S.
    Miguel Juarez-Salcedo, Luis
    Nuevo, Irene
    Guillen, Helga
    Arbeteta, Jaime
    Golbano, Nuria
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 206 - 206
  • [38] Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q
    Smoley, Stephanie A.
    Fink, Stephanie R.
    Paternoster, Sarah F.
    Stockero, Kimberly J.
    Nguyen, Lai P.
    Nguyen, Phuong L.
    Hanson, Curtis A.
    Dewald, Gordon W.
    CANCER GENETICS AND CYTOGENETICS, 2007, 173 (02) : 144 - 149
  • [39] ANALYSIS OF ASXL1 MUTATIONS AND CORRELATION WITH CHROMOSOMAL ALTERATIONS IN ACUTE MYELOID LEUKEMIA
    Kakosaiou, K.
    Daraki, A.
    Apostolou, P.
    Zachaki, S.
    Pagoni, M.
    Sambani, C.
    Dimitriadis, G.
    Pappa, V.
    Manola, K.
    HAEMATOLOGICA, 2015, 100 : 359 - 360
  • [40] Interstitial deletion of 20q in a patient with Waldenstrom macroglobulinemia following chemotherapy
    Blann, MM
    Velagaleti, GVN
    Morgan, DL
    Martinez, RE
    Conlin, PA
    Tonk, VS
    CANCER GENETICS AND CYTOGENETICS, 2002, 132 (02) : 145 - 148
12345